{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "Massachusetts Institute of Technology, Cambridge, MA, USA",
    "3Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA",
    "1Massachusetts Institute of Technology, Cambridge, MA, USA",
    "Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA",
    "1Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA",
    "The Scripps Research Institute, La Jolla, CA, USA"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 10,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Robert Langer"
    },
    {
      "affs": [
        1
      ],
      "name": "Stefani Spranger"
    },
    {
      "affs": [
        2
      ],
      "name": "Vidit Bhandarkar"
    },
    {
      "affs": [
        2
      ],
      "name": "Sean-Luc Shanahan"
    },
    {
      "affs": [
        3
      ],
      "name": "Tyler Jacks"
    },
    {
      "affs": [
        4
      ],
      "name": "Molly Carney"
    },
    {
      "affs": [
        0
      ],
      "name": "Brett H Pogostin"
    },
    {
      "affs": [
        0
      ],
      "name": "Taylor Heim"
    },
    {
      "affs": [
        0
      ],
      "name": "Ana Jaklenec"
    },
    {
      "affs": [
        5
      ],
      "name": "Darrell J Irvine"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/6bk5gr3r371kv.bib",
  "cited_by": 0,
  "doi": "10.1136/jitc-2026-sitc2026.0942",
  "fulltext_url": null,
  "id": "6bk5gr3r371kv",
  "issns": [
    "2051-1426"
  ],
  "landing_url": "https://doi.org/10.1136/jitc-2026-sitc2026.0942",
  "language": "en",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "lcc",
      "RC254-282"
    ],
    [
      "openalex",
      "2403|Immunotherapy and Immune Responses"
    ]
  ],
  "openalex": "W7225199434",
  "pdf_url": "https://jitc.bmj.com/content/14/Suppl_2/A1069.full.pdf",
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-07",
  "publisher": "BMJ Publishing Group",
  "ris": "https://research.draconitic.com/paper/6bk5gr3r371kv.ris",
  "sources": [
    {
      "first_seen": "2026-11-08T14:20:41Z",
      "native_id": "0411461d8b854f418b3b73811420270a",
      "source": "doaj",
      "url": "https://doi.org/10.1136/jitc-2026-sitc2026.0942"
    }
  ],
  "subjects": [
    {
      "field": "biology",
      "origin": "openalex:2403|Immunotherapy and Immune Responses",
      "subfield": "immunology"
    }
  ],
  "title": "942 cDC1-independent tumor rejection: CD45-targeted IL-12 reveals a cDC2–CD4+ T cell axis as a driver of lung tumor immunity",
  "title_text": "942 cDC1-independent tumor rejection: CD45-targeted IL-12 reveals a cDC2–CD4+ T cell axis as a driver of lung tumor immunity",
  "type": "peer-reviewed",
  "updated_at": "2026-11-09T14:21:01Z",
  "url": "https://research.draconitic.com/paper/6bk5gr3r371kv",
  "venue": "Journal for ImmunoTherapy of Cancer",
  "versions": []
}